Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial (SUMMIT)
Research payments
$126,942
Through program year 2019, $126,942 in research payments was reported against Hydrus Microstent for Refractory Open-Angle Glaucoma: a Prospective| Multicenter Clinical Trial (SUMMIT), across 36 payments, paid by Ivantis, Inc.
- Paid by
- Ivantis, Inc
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $126,942 | 36 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Kent Bashford Fort Collins, CO Named on 5 payments
- Inder Singh Racine, WI Named on 4 payments
- Steven Vold Fayetteville, AR Named on 4 payments
- Mark Gallardo El Paso, TX Named on 4 payments
- Robert Feldman Houston, TX Named on 3 payments
- Manjool Shah Grand Blanc, MI Named on 3 payments
- Matthew Emanuel Dallas, TX Named on 3 payments
- Mohammed El Mallah Ocala, FL Named on 3 payments
- Arsham Sheybani Saint Louis, MO Named on 2 payments
- David Godfrey Dallas, TX Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.